Follow-up of all women with no prior thyroid diagnosis when stratified by levels of thyrotropin receptor antibodies and thyrotropin in early pregnancy
. | TSH < 0.1 mIU/L . | . | . | . | . | . | TSH ≥ 0.1 mIU/L . | . | . | . | . | . |
---|---|---|---|---|---|---|---|---|---|---|---|---|
. | TRAb > 1.0 IU/L . | . | . | TRAb ≤ 1.0 IU/L . | . | . | TRAb > 1.0 IU/L . | . | . | TRAb ≤ 1.0 IU/L . | . | . |
. | n = 21 . | . | . | n = 393 . | . | . | n = 26 . | . | . | n = 542 . | . | . |
. | n . | RF (%) . | 95% CI . | n . | RF (%) . | 95% CI . | n . | RF (%) . | 95% CI . | n . | RF (%) . | 95% CI . |
Later hyperthyroid diagnosis | 11 | 52.4 | 29.8-74.3 | 33 | 8.4 | 5.9-11.6 | < 5 | N/A | N/A | < 5 | N/A | N/A |
Later ATD treatment | 10 | 47.6 | 25.7-70.2 | 17 | 4.3 | 2.5-6.8 | < 5 | N/A | N/A | < 5 | N/A | N/A |
Later thyroid surgery or radioiodine treatment | < 5 | N/A | N/A | 5 | 1.3 | 0.4-2.9 | < 5 | N/A | N/A | < 5 | N/A | N/A |
Later pregnancy | 9 | 42.9 | 21.8-66.0 | 154 | 39.2 | 34.3-44.2 | 11 | 42.3 | 23.4-63.1 | 271 | 50.0 | 45.7-54.3 |
Hyperthyroidism in pregnancy or 2 y post partuma | 5 | 23.8 | 8.2-47.2 | 10 | 2.5 | 1.2-4.6 | < 5 | N/A | N/A | < 5 | N/A | N/A |
ATD in pregnancy or 2 y post partumb | 5 | 23.8 | 8.2-47.2 | 5 | 1.3 | 0.4-2.9 | < 5 | N/A | N/A | < 5 | N/A | N/A |
. | TSH < 0.1 mIU/L . | . | . | . | . | . | TSH ≥ 0.1 mIU/L . | . | . | . | . | . |
---|---|---|---|---|---|---|---|---|---|---|---|---|
. | TRAb > 1.0 IU/L . | . | . | TRAb ≤ 1.0 IU/L . | . | . | TRAb > 1.0 IU/L . | . | . | TRAb ≤ 1.0 IU/L . | . | . |
. | n = 21 . | . | . | n = 393 . | . | . | n = 26 . | . | . | n = 542 . | . | . |
. | n . | RF (%) . | 95% CI . | n . | RF (%) . | 95% CI . | n . | RF (%) . | 95% CI . | n . | RF (%) . | 95% CI . |
Later hyperthyroid diagnosis | 11 | 52.4 | 29.8-74.3 | 33 | 8.4 | 5.9-11.6 | < 5 | N/A | N/A | < 5 | N/A | N/A |
Later ATD treatment | 10 | 47.6 | 25.7-70.2 | 17 | 4.3 | 2.5-6.8 | < 5 | N/A | N/A | < 5 | N/A | N/A |
Later thyroid surgery or radioiodine treatment | < 5 | N/A | N/A | 5 | 1.3 | 0.4-2.9 | < 5 | N/A | N/A | < 5 | N/A | N/A |
Later pregnancy | 9 | 42.9 | 21.8-66.0 | 154 | 39.2 | 34.3-44.2 | 11 | 42.3 | 23.4-63.1 | 271 | 50.0 | 45.7-54.3 |
Hyperthyroidism in pregnancy or 2 y post partuma | 5 | 23.8 | 8.2-47.2 | 10 | 2.5 | 1.2-4.6 | < 5 | N/A | N/A | < 5 | N/A | N/A |
ATD in pregnancy or 2 y post partumb | 5 | 23.8 | 8.2-47.2 | 5 | 1.3 | 0.4-2.9 | < 5 | N/A | N/A | < 5 | N/A | N/A |
. | Median . | 95% CI . | Median . | 95% CI . | . | . | . | . |
---|---|---|---|---|---|---|---|---|
No. of later ATD prescriptionsc | 13 | 4-25 | 3 | 3-7 |
. | Median . | 95% CI . | Median . | 95% CI . | . | . | . | . |
---|---|---|---|---|---|---|---|---|
No. of later ATD prescriptionsc | 13 | 4-25 | 3 | 3-7 |
Abbreviations: β-hCG, β-human chorionic gonadotropin; ATD, antithyroid drugs; BMI, body mass index; fT4, free thyroxine; N/A, not available; RF, relative frequency; TRAb, thyrotropin receptor antibodies; TSH, thyrotropin.
aHospital diagnosis of hyperthyroidism while pregnant or 2 years post partum.
bPrescription of ATD in the period from 1 month before pregnancy until 2 years post partum.
cNumber of prescriptions from the first prescription until December 31, 2020.
Follow-up of all women with no prior thyroid diagnosis when stratified by levels of thyrotropin receptor antibodies and thyrotropin in early pregnancy
. | TSH < 0.1 mIU/L . | . | . | . | . | . | TSH ≥ 0.1 mIU/L . | . | . | . | . | . |
---|---|---|---|---|---|---|---|---|---|---|---|---|
. | TRAb > 1.0 IU/L . | . | . | TRAb ≤ 1.0 IU/L . | . | . | TRAb > 1.0 IU/L . | . | . | TRAb ≤ 1.0 IU/L . | . | . |
. | n = 21 . | . | . | n = 393 . | . | . | n = 26 . | . | . | n = 542 . | . | . |
. | n . | RF (%) . | 95% CI . | n . | RF (%) . | 95% CI . | n . | RF (%) . | 95% CI . | n . | RF (%) . | 95% CI . |
Later hyperthyroid diagnosis | 11 | 52.4 | 29.8-74.3 | 33 | 8.4 | 5.9-11.6 | < 5 | N/A | N/A | < 5 | N/A | N/A |
Later ATD treatment | 10 | 47.6 | 25.7-70.2 | 17 | 4.3 | 2.5-6.8 | < 5 | N/A | N/A | < 5 | N/A | N/A |
Later thyroid surgery or radioiodine treatment | < 5 | N/A | N/A | 5 | 1.3 | 0.4-2.9 | < 5 | N/A | N/A | < 5 | N/A | N/A |
Later pregnancy | 9 | 42.9 | 21.8-66.0 | 154 | 39.2 | 34.3-44.2 | 11 | 42.3 | 23.4-63.1 | 271 | 50.0 | 45.7-54.3 |
Hyperthyroidism in pregnancy or 2 y post partuma | 5 | 23.8 | 8.2-47.2 | 10 | 2.5 | 1.2-4.6 | < 5 | N/A | N/A | < 5 | N/A | N/A |
ATD in pregnancy or 2 y post partumb | 5 | 23.8 | 8.2-47.2 | 5 | 1.3 | 0.4-2.9 | < 5 | N/A | N/A | < 5 | N/A | N/A |
. | TSH < 0.1 mIU/L . | . | . | . | . | . | TSH ≥ 0.1 mIU/L . | . | . | . | . | . |
---|---|---|---|---|---|---|---|---|---|---|---|---|
. | TRAb > 1.0 IU/L . | . | . | TRAb ≤ 1.0 IU/L . | . | . | TRAb > 1.0 IU/L . | . | . | TRAb ≤ 1.0 IU/L . | . | . |
. | n = 21 . | . | . | n = 393 . | . | . | n = 26 . | . | . | n = 542 . | . | . |
. | n . | RF (%) . | 95% CI . | n . | RF (%) . | 95% CI . | n . | RF (%) . | 95% CI . | n . | RF (%) . | 95% CI . |
Later hyperthyroid diagnosis | 11 | 52.4 | 29.8-74.3 | 33 | 8.4 | 5.9-11.6 | < 5 | N/A | N/A | < 5 | N/A | N/A |
Later ATD treatment | 10 | 47.6 | 25.7-70.2 | 17 | 4.3 | 2.5-6.8 | < 5 | N/A | N/A | < 5 | N/A | N/A |
Later thyroid surgery or radioiodine treatment | < 5 | N/A | N/A | 5 | 1.3 | 0.4-2.9 | < 5 | N/A | N/A | < 5 | N/A | N/A |
Later pregnancy | 9 | 42.9 | 21.8-66.0 | 154 | 39.2 | 34.3-44.2 | 11 | 42.3 | 23.4-63.1 | 271 | 50.0 | 45.7-54.3 |
Hyperthyroidism in pregnancy or 2 y post partuma | 5 | 23.8 | 8.2-47.2 | 10 | 2.5 | 1.2-4.6 | < 5 | N/A | N/A | < 5 | N/A | N/A |
ATD in pregnancy or 2 y post partumb | 5 | 23.8 | 8.2-47.2 | 5 | 1.3 | 0.4-2.9 | < 5 | N/A | N/A | < 5 | N/A | N/A |
. | Median . | 95% CI . | Median . | 95% CI . | . | . | . | . |
---|---|---|---|---|---|---|---|---|
No. of later ATD prescriptionsc | 13 | 4-25 | 3 | 3-7 |
. | Median . | 95% CI . | Median . | 95% CI . | . | . | . | . |
---|---|---|---|---|---|---|---|---|
No. of later ATD prescriptionsc | 13 | 4-25 | 3 | 3-7 |
Abbreviations: β-hCG, β-human chorionic gonadotropin; ATD, antithyroid drugs; BMI, body mass index; fT4, free thyroxine; N/A, not available; RF, relative frequency; TRAb, thyrotropin receptor antibodies; TSH, thyrotropin.
aHospital diagnosis of hyperthyroidism while pregnant or 2 years post partum.
bPrescription of ATD in the period from 1 month before pregnancy until 2 years post partum.
cNumber of prescriptions from the first prescription until December 31, 2020.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.